Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W3140349894', 'doi': None, 'title': 'Paclitaxel based vs oxaliplatin based regimens for advanced gastric cancer', 'display_name': 'Paclitaxel based vs oxaliplatin based regimens for advanced gastric cancer', 'publication_year': 2011, 'publication_date': '2011-01-01', 'ids': {'openalex': 'https://openalex.org/W3140349894', 'mag': '3140349894'}, 'language': 'zh-cn', 'primary_location': {'is_oa': False, 'landing_page_url': 'http://www.cqvip.com/QK/84123X/201108/37862204.html', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306541009', 'display_name': '世界胃肠病学杂志:英文版(电子版)', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': None, 'host_organization_name': None, 'host_organization_lineage': [], 'host_organization_lineage_names': [], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': [], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5011216979', 'display_name': 'Xiaodong', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Xiao-Dong', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5113436937', 'display_name': 'Li', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Li', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5110752438', 'display_name': 'Hua', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Hua', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5106121500', 'display_name': 'Shen', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Shen', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5008754115', 'display_name': 'ling-Ting', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'ling-Ting', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5114257345', 'display_name': 'Jiang', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Jiang', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5059809598', 'display_name': 'Han-Ze', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Han-Ze', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5113468302', 'display_name': 'Zhang', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Zhang', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5106023602', 'display_name': 'Xiao Xiao', 'orcid': 'https://orcid.org/0009-0009-9618-4302'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Xiao', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5110127139', 'display_name': 'Z. Zheng', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Zheng', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5060965735', 'display_name': 'Yongqian', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Yong-Qian', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5112156827', 'display_name': 'Shu', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Shu', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5030372916', 'display_name': 'Chang-Ping', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Chang-Ping', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5109862817', 'display_name': 'Wu', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Wu', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 65}, 'biblio': {'volume': '17', 'issue': '8', 'first_page': '1082', 'last_page': '1087'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10696', 'display_name': 'Gastric Cancer Management and Outcomes', 'score': 0.9995, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10696', 'display_name': 'Gastric Cancer Management and Outcomes', 'score': 0.9995, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10417', 'display_name': 'Lung Cancer Treatments and Mutations', 'score': 0.9947, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11067', 'display_name': 'Colorectal Cancer Treatments and Studies', 'score': 0.9912, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/folfox', 'display_name': 'FOLFOX', 'score': 0.98565507}], 'concepts': [{'id': 'https://openalex.org/C2778260052', 'wikidata': 'https://www.wikidata.org/wiki/Q117636', 'display_name': 'FOLFOX', 'level': 5, 'score': 0.98565507}, {'id': 'https://openalex.org/C2780962732', 'wikidata': 'https://www.wikidata.org/wiki/Q422327', 'display_name': 'Oxaliplatin', 'level': 4, 'score': 0.9633038}, {'id': 'https://openalex.org/C2778239845', 'wikidata': 'https://www.wikidata.org/wiki/Q412415', 'display_name': 'Cisplatin', 'level': 3, 'score': 0.70519674}, {'id': 'https://openalex.org/C2777292972', 'wikidata': 'https://www.wikidata.org/wiki/Q423762', 'display_name': 'Paclitaxel', 'level': 3, 'score': 0.68796647}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.46152252}, {'id': 'https://openalex.org/C2776694085', 'wikidata': 'https://www.wikidata.org/wiki/Q974135', 'display_name': 'Chemotherapy', 'level': 2, 'score': 0.3897965}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.32591516}, {'id': 'https://openalex.org/C526805850', 'wikidata': 'https://www.wikidata.org/wiki/Q188874', 'display_name': 'Colorectal cancer', 'level': 3, 'score': 0.3157574}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.25718546}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'http://www.cqvip.com/QK/84123X/201108/37862204.html', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306541009', 'display_name': '世界胃肠病学杂志:英文版(电子版)', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': None, 'host_organization_name': None, 'host_organization_lineage': [], 'host_organization_lineage_names': [], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.7, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': [], 'abstract_inverted_index': {'瞄准:为了比较,加': [0], 'cisplatin': [1, 28], '(PCF': [2], ')': [3, 12, 21, 68, 80], '与氟尿嘧啶相结合的': [4], 'paclitaxel': [5, 16], '的功效和安全,和': [6], 'oxaliplatin': [7, 40], '为先进胃的癌症(自动增益控制)': [8], '把正': [9], 'leucovorin': [10, 48], '(FOLFOX-4': [11], '政体与氟尿嘧啶相结合。方法:有自动增益控制的': [13], '94': [14], '个病人随机被分配在天收到': [15], '(': [17, 29, 41, 49], '50': [18], 'mg/m2': [19, 31, 37, 43, 51, 55, 59], 'iv': [20, 32, 38, 44, 52, 56, 60], '1': [22, 46, 62, 66, 95, 107], ',': [23, 27], '8': [24], '和': [25, 63, 71, 75, 77, 83, 88, 92, 98, 102, 120, 123], '15': [26], '20': [30], ')和天': [33], '1-5': [34], '上的氟尿嘧啶(': [35], '750': [36], '),或': [39], '85': [42], ')和白天': [45], '上的': [47], '200': [50], '),在天由大丸药氟尿嘧啶(': [53], '400': [54], ')和氟尿嘧啶(': [57], '600': [58], ')列在后面': [61], '2': [64], '。主要结束点是': [65], '年的幸存时间。结果:病人的全面反应率(ORR': [67], '分别地是': [69, 81], '48.0%': [70], '45.5%': [72], '到': [73], 'PCF': [74, 87, 97, 109, 119], 'FOLFOX-4。PCF': [76], 'FOLFOX-4': [78, 89, 99, 115, 121, 124], '的疾病控制率(DCR': [79], '82.0%': [82], '81.8%': [84], '。分别地,病人的中部的幸存时间(山区标准时间)': [85], '在有': [86], '的治疗以后是': [90, 100], '10.8': [91], '9.9': [93], '瞬间。分别地,病人的': [94], '年的幸存率在有': [96], '36.0%': [101], '34.1%': [103], '。没有重要差别在在二个组之间的': [104], 'ORR,': [105], 'DCR,山区标准时间或': [106], '年的幸存率被观察。最普通的不利事件是贫血症,恶心并且呕吐,并且在': [108], '的等级': [110], '3/4': [111, 117], '脱发治疗组,和贫血症,分级': [112], '1/2': [113], '在': [114], '治疗的毒害神经的效果和等级': [116], '嗜中性白血球减少症组。结论:有自动增益控制的病人让类似的回答与类似的幸存率评价到': [118], '政体。PCF': [122], '政体为自动增益控制象有希望的治疗有效、可容忍。': [125]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W3140349894', 'counts_by_year': [], 'updated_date': '2024-12-06T05:25:28.947137', 'created_date': '2021-04-13'}